The methylisothiazolinone epidemic goes along with changing patients' characteristics - After cosmetics, industrial applications are the focus
- PMID: 31599977
- DOI: 10.1111/cod.13414
The methylisothiazolinone epidemic goes along with changing patients' characteristics - After cosmetics, industrial applications are the focus
Abstract
Background: Sensitization to methylisothiazolinone (MI) has seen an exceptional epidemic, mainly attributed to its use in cosmetics.
Objectives: To trace the epidemic of MI allergy (2009-2018), and to analyze a possible change of patients' characteristics.
Methods: Informationsverbund Dermatologischer Kliniken-data of patients patch tested between 2009 and 2018 with MI (0.05% aq.) were analyzed concerning anamnestic items and sensitization frequencies.
Results: Overall, 4.9% reacted positive to MI. Comparing sensitization to MI in three periods (2009, 2013/14, and 2017/18), there was an increase to 7% in 2013 and a decrease to 3.4% in 2018. The MOAHLFA Index (M=Men, O=Occupational Dermatitis, A=Atopic Dermatitis, L=Leg Dermatitis, F=Face Dermatitis, A= Age > 40) for the period 2013/14 is characterized by a lower proportion of occupational dermatitis and a higher proportion of face dermatitis. The period 2017/18 is characterized by increases of occupational dermatitis and hand dermatitis, and a decrease of face dermatitis. Painters, personal care workers, and hairdressers were particularly affected. Sensitization in hairdressers and personal care workers (mostly cosmeticians) decreased after the peak in 2013/14, whereas sensitization to MI in painters continued to increase.
Conclusions: After an unprecedented epidemic of MI allergy, mainly caused by its use in cosmetics, the continuous use of MI in industrial applications, for example, paints, and subsequent sensitization remain a matter of concern.
Keywords: CAS no. 2682-20-4; clinical epidemiology; contact sensitization; face dermatitis; methylisothiazolinone; occupational dermatitis; patch testing.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Geier J, Lessmann H, Schnuch A, Uter W. Recent increase in allergic reactions to methylchloroisothiazolinone/methylisothiazolinone: is methylisothiazolinone the culprit? Contact Dermatitis. 2012;67:334-341.
-
- Herman A, Aerts O, de Montjoye L, Tromme I, Goossens A, Baeck M. Isothiazolinone derivatives and allergic contact dermatitis: a review and update. J Eur Acad Dermatol Venereol. 2019;33:267-276.
-
- Uter W, Amario-Hita JC, Balato A, et al. European surveillance system on contact allergies (ESSCA): results with the European baseline series, 2013/14. J Eur Acad Dermatol Venereol. 2017;31:1516-1525.
-
- Zirwas MJ, Hamann D, Warshaw EM, et al. Epidemic of isothiazolinone allergy in North America: prevalence data from the north American contact dermatitis group, 2013-2014. Dermatitis. 2017;28:204-209.
-
- DeKoven JG, Warshaw EM, Zug KA, et al. North American contact dermatitis group patch test results: 2015-2016. Dermatitis. 2018;29:297-309.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical